Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies.

[1]  O. Y. Hu,et al.  Mucoadhesive buccal disks for novel nalbuphine prodrug controlled delivery: effect of formulation variables on drug release and mucoadhesive performance. , 1999, International journal of pharmaceutics.

[2]  O. Y. Hu,et al.  Controlled release of nalbuphine prodrugs from biodegradable polymeric matrices: influence of prodrug hydrophilicity and polymer composition , 1998 .

[3]  S. Ho,et al.  Paw pressure test in the rabbit: a new animal model for the study of pain. , 1996, Acta anaesthesiologica Sinica.

[4]  T. Kondo,et al.  Preparation of Poly(D,L‐lactide) and Copoly(lactide‐glycolide) Microspheres of Uniform Size , 1996, The Journal of pharmacy and pharmacology.

[5]  N. Udupa,et al.  Biodegradable Injectable Implant Systems for Long Term Drug Delivery Using Poly (Lactic‐co‐glycolic) Acid Copolymers , 1996, The Journal of pharmacy and pharmacology.

[6]  D. Wise,et al.  Mechanisms of isoniazid release from poly(d,l-lactide-co-glycolide) matrices prepared by dry-mixing and low density polymeric foam methods. , 1996, Journal of pharmaceutical sciences.

[7]  S. Ho,et al.  Determination of nalbuphine by high-performance liquid chromatography with ultraviolet detection: application to human and rabbit pharmacokinetic studies. , 1996, Journal of chromatography. B, Biomedical applications.

[8]  C. Shih.  Chain-end scission in acid catalyzed hydrolysis of poly (d,l-lactide) in solution , 1995 .

[9]  Lisa Brannon-Peppas,et al.  Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery , 1995 .

[10]  K. Peck,et al.  Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins , 1995 .

[11]  Sumie Yoshioka,et al.  Effect of temperature on mechanisms of drug release and matrix degradation of poly(d,l-lactide) microspheres , 1994 .

[12]  D. Pichora,et al.  Controlled release of albumin from biodegradable poly(DL-lactide) cylinders , 1993 .

[13]  Yoshiaki,et al.  Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. , 1993 .

[14]  M. Vert,et al.  Gentamycin/poly (lactic acid) blends aimed at sustained release local antibiotic therapy administered per-operatively. III. The case of gentamycin sulfate in films prepared from high and low molecular weight poly (DL-lactic acids) , 1993 .

[15]  Y. Ikada,et al.  Controlled cisplatin delivery system using poly(D,L-lactic acid). , 1992, Biomaterials.

[16]  S. Leucuţa,et al.  The kinetics of in vitro release and the pharmacokinetics of miotic response in rabbits of gelatin and albumin microspheres with pilocarpine , 1989 .

[17]  H. Okada,et al.  Controlled-release of leuprolide acetate from polylactic acid or copoly(lactic/glycolic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer. , 1988, Chemical & pharmaceutical bulletin.

[18]  G. Drummond,et al.  A dose-response study with nalbuphine hydrochloride for pain in patients after upper abdominal surgery. , 1987, British journal of anaesthesia.

[19]  L. M. Sanders,et al.  Prolonged controlled-release of nafarelin, a luteinizing hormone-releasing hormone analogue, from biodegradable polymeric implants: influence of composition and molecular weight of polymer. , 1986, Journal of pharmaceutical sciences.